GNH USA

Europe — EMA

Mofuder (Mometasone Furoate)

GNH USA supplies Mofuder (Mometasone Furoate), a topical corticosteroid for atopic dermatitis, psoriasis and other inflammatory skin disorders.

Request sourcing

1
Pack/s

What is Mometasone Furoate?

Mometasone furoate, the active ingredient in Mofuder, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory skin disorders such as atopic dermatitis, psoriasis, contact dermatitis and other related conditions in both adult and pediatric patients. The product is intended for short‑term application to control flare‑ups while minimizing systemic absorption.

GNH USA supplies Mofuder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

What is Mometasone Furoate used for?

Mometasone furoate is a topical corticosteroid that reduces inflammation in various skin disease categories. - Atopic dermatitis: decreases redness, itching and scaling, helping to control flare‑ups. - Psoriasis: softens thick plaques, reduces erythema and scaling, and improves skin texture. - Contact dermatitis: alleviates irritation and inflammation caused by allergens or irritants. - Other inflammatory skin disorders: provides anti‑inflammatory relief in conditions such as seborrheic dermatitis or nummular eczema. - Lichen planus: reduces itching, flattens violaceous papules and limits disease progression. - Discoid lupus erythematosus: diminishes cutaneous inflammation and erythema.

What are the side effects of Mometasone Furoate?

Topical application of Mometasone furoate may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects: - Burning sensation - Itching - Dryness

Serious or Rare Side Effects: - Skin atrophy - Hypopigmentation - Secondary bacterial or fungal infection

What precautions apply to Mometasone Furoate?

When using Mometasone furoate, certain precautions help minimize risks and ensure safe therapy. - Pregnancy: safety not established; use only if benefit outweighs risk. - Children: limit duration and surface area; follow pediatric guidance. - Occlusion: avoid covering treated area unless directed, as it may increase absorption. - Infected skin: do not apply on bacterial, viral or fungal infections without medical advice. - Large surface area: avoid extensive application exceeding recommended body surface percentage. - Store at room temperature: keep in original container, protect from moisture and light.

What does Mometasone Furoate interact with?

Mometasone furoate can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Immunosuppressants (e.g., cyclosporine): increased risk of infection. - Antifungal agents (e.g., ketoconazole): may reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Photosensitizing drugs (e.g., tetracyclines): heightened photosensitivity risk. - Topical antibiotics (e.g., mupirocin): potential for local irritation. - Live vaccines: possible diminished immune response.

Frequently asked questions

What conditions is Mofuder used to treat?+
Mofuder contains mometasone furoate, a topical corticosteroid indicated for inflammatory skin disorders such as atopic dermatitis, psoriasis, contact dermatitis and other related conditions. It is prescribed to reduce redness, itching, scaling and plaque formation on affected skin areas.
How does mometasone furoate work to reduce skin inflammation?+
Mometasone furoate penetrates skin cells and binds to intracellular glucocorticoid receptors. The resulting complex alters gene transcription, suppressing pro‑inflammatory cytokines and chemokines while increasing anti‑inflammatory proteins. This cascade reduces cellular infiltration, edema and the overall inflammatory response in the skin.
What is the usual dose of Mofuder?+
The specific dose and frequency of Mofuder are determined by the prescribing healthcare professional based on the severity of the condition, patient age and the area of skin to be treated. Typically, a thin layer is applied to the affected area once or twice daily for a short period.
Is Mofuder safe to use during pregnancy or while breastfeeding?+
Safety data for mometasone furoate in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any possible risk to the fetus, and caution is advised when breastfeeding.
How do I order Mofuder from GNH USA?+
To request Mofuder, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mofuder compare with other topical steroids?+
Mometasone furoate is considered a high‑potency topical corticosteroid, offering stronger anti‑inflammatory effects than low‑ to medium‑potency agents such as hydrocortisone. Compared with other high‑potency steroids, its efficacy is similar, but formulation differences may affect skin feel and absorption, influencing clinician preference.
How should Mofuder be stored and handled?+
Mofuder should be stored at room temperature, below 25 °C, in its original container. Keep the product away from direct sunlight, moisture and heat sources. Ensure the cap is tightly closed after each use to maintain stability and potency.
How is Mofuder applied to the skin?+
Apply a thin layer of Mofuder to the clean, dry affected skin area, gently rubbing it in until it disappears. Follow the prescriber’s instructions regarding frequency and duration, and avoid covering the treated area with occlusive dressings unless specifically advised.
What are the most serious risks associated with using Mofuder?+
Serious, though rare, risks include skin atrophy, hypopigmentation and secondary bacterial or fungal infections. Systemic absorption can lead to adrenal suppression or other corticosteroid‑related effects, especially with extensive or prolonged use. Patients should report any unusual skin changes or systemic symptoms promptly.
Who should not use Mofuder?+
Mofuder is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided on untreated viral, bacterial or fungal skin infections, and in patients requiring systemic corticosteroid therapy for unrelated conditions without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mometasone Furoate
Route
Cutaneous Use
Manufacturer
Bausch Health Ireland Limited
Origin
EU

Related products